Naheed is the President of Recursion Canada, the Canadian wholly-owned subsidiary of Recursion Pharmaceuticals (NASDAQ: RXRX), a clinical-stage TechBio company decoding biology by integrating technological innovations across biology, chemistry, automation, data science and engineering to industrialize drug discovery. Prior to joining Recursion, Naheed was the Co-founder, President and CEO of Cyclica, a Toronto-based biotech company (acquired by Recursion in May 2023). At Cyclica, Naheed had the distinct privilege of working with an incredibly talented and dedicated team that was considered one of the pioneers of what is now the increasingly hot space of AI for Drug Discovery and Development. Naheed was also a co-founder and Board Member of EntheogeniX Biosciences, a psychedelic inspired biotech company for mental health, is co-founder of the Alliance for Artificial Intelligence in Healthcare (AAIH) for which he served as Chair until May 2023, a Board Member of the Ontario Bioscience Innovation Organization (OBIO), and Board Member at Life Sciences of Ontario (LSO).